Climb Bio, Inc. (CLYM)
11.50
+0.49
(+4.45%)
USD |
NASDAQ |
Nov 10, 10:07
Climb Bio Cash and Short Term Investments (Quarterly) : 205.42M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 205.42M |
| June 30, 2026 | 183.12M |
| March 31, 2026 | 109.56M |
| December 31, 2025 | 101.08M |
| September 30, 2025 | 86.90M |
| June 30, 2025 | 84.70M |
| March 31, 2025 | 98.06M |
| December 31, 2024 | 150.92M |
| September 30, 2024 | 193.35M |
| June 30, 2024 | 223.14M |
| March 31, 2024 | 105.03M |
| December 31, 2023 | 106.80M |
| Date | Value |
|---|---|
| September 30, 2023 | 107.43M |
| June 30, 2023 | 102.63M |
| March 31, 2023 | 109.37M |
| December 31, 2022 | 123.57M |
| September 30, 2022 | 122.62M |
| June 30, 2022 | 122.95M |
| March 31, 2022 | 123.94M |
| December 31, 2021 | 136.48M |
| September 30, 2021 | 146.02M |
| June 30, 2021 | 99.48M |
| March 31, 2021 | 47.91M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 456.22M |
| Cullinan Therapeutics, Inc. | 334.54M |
| Q32 Bio, Inc. | 289.59M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |